BSX

64.23

1.28% 0.81

Handel nachbörslich: 64.27 0.04 +0.06%

Boston Scientific Corp (BSX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$63.42

Offen:

$64.08

24-Stunden-Volumen:

12.09M

Relative Volume:

0.74

Marktkapitalisierung:

$95.46B

Einnahmen:

$20.08B

Nettoeinkommen (Verlust:

$2.89B

KGV:

33.12

EPS:

1.9391

Netto-Cashflow:

$3.66B

1W Leistung:

+3.95%

1M Leistung:

-9.79%

6M Leistung:

-35.28%

1J Leistung:

-32.47%

1-Tages-Spanne:

$63.90

$64.89

1-Wochen-Bereich:

$61.44

$65.56

52-Wochen-Spanne:

$60.59

$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Firmenname

Boston Scientific Corp

Sektor

Healthcare (1116)

Branche

Medical Devices (142)

Telefon

508-683-4000

Adresse

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA

Mitarbeiter

59,000

Twitter

@bostonsci

Nächster Verdiensttermin

2026-04-22

Neueste SEC-Einreichungen

BSX's Discussions on Twitter

Compare BSX vs ABT, SYK, MDT, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BSX Boston Scientific Corp	64.23	95.46B	20.08B	2.89B	3.66B	1.9391
ABT Abbott Laboratories	96.81	168.22B	45.13B	6.28B	7.40B	3.5895
SYK Stryker Corp	343.32	131.49B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	86.19	110.66B	35.48B	4.64B	5.41B	3.582
EW Edwards Lifesciences Corp	80.99	46.69B	6.07B	1.06B	1.34B	1.8063

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-30	Herabstufung	Raymond James	Strong Buy → Outperform
2025-10-03	Herabstufung	Erste Group	Buy → Hold
2025-09-08	Hochstufung	Oppenheimer	Perform → Outperform
2025-06-16	Eingeleitet	Leerink Partners	Outperform
2025-04-16	Hochstufung	Needham	Hold → Buy
2025-01-10	Hochstufung	Deutsche Bank	Hold → Buy
2024-10-18	Herabstufung	Needham	Buy → Hold
2024-05-30	Eingeleitet	Goldman	Buy
2024-02-01	Hochstufung	Mizuho	Neutral → Buy
2023-07-19	Eingeleitet	Robert W. Baird	Outperform
2023-06-30	Eingeleitet	CL King	Buy
2023-05-30	Fortgesetzt	Morgan Stanley	Overweight
2023-03-29	Eingeleitet	UBS	Buy
2022-12-22	Eingeleitet	Mizuho	Neutral
2022-12-20	Fortgesetzt	Citigroup	Buy
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Buy
2022-07-06	Eingeleitet	Wolfe Research	Outperform
2022-05-27	Hochstufung	Needham	Hold → Buy
2022-04-13	Fortgesetzt	Truist	Buy
2022-03-02	Fortgesetzt	BofA Securities	Buy
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-05-26	Herabstufung	Needham	Buy → Hold
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-15	Eingeleitet	Atlantic Equities	Overweight
2020-09-17	Eingeleitet	Truist	Buy
2020-09-11	Eingeleitet	Wolfe Research	Peer Perform
2020-04-22	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-04-01	Hochstufung	Goldman	Neutral → Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Neutral
2020-02-06	Fortgesetzt	BTIG Research	Buy
2019-12-30	Bestätigt	Cowen	Outperform
2019-12-19	Herabstufung	Needham	Strong Buy → Buy
2019-09-05	Fortgesetzt	JP Morgan	Overweight
2019-09-03	Fortgesetzt	Barclays	Overweight
2019-05-13	Hochstufung	Evercore ISI	In-line → Outperform
2018-11-28	Eingeleitet	UBS	Buy
2018-10-16	Eingeleitet	Barclays	Overweight
2018-10-02	Bestätigt	Morgan Stanley	Overweight
2018-09-07	Bestätigt	Needham	Strong Buy
2018-09-04	Hochstufung	Jefferies	Hold → Buy
2018-07-06	Bestätigt	Needham	Strong Buy
2018-06-27	Eingeleitet	Bernstein	Outperform
2018-04-26	Bestätigt	Needham	Strong Buy

Alle ansehen

Boston Scientific Corp Aktie (BSX) Neueste Nachrichten

Apr 18, 2026

ROSEN, THE FIRST FILING FIRM, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Apr 18, 2026

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Apr 18, 2026

Boston Scientific Advances Fainting Detection Study With New Wearable Data Initiative - TipRanks

Apr 18, 2026

Boston Scientific Corporation $BSX Position Lifted by Ninety One UK Ltd - MarketBeat

Apr 18, 2026

Asset Management One Co. Ltd. Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat

Apr 18, 2026

AE Wealth Management LLC Boosts Stake in Boston Scientific Corporation $BSX - MarketBeat

Apr 18, 2026

Apr 17, 2026

Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus

Apr 17, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class ActionBSX - TMX Newsfile

Apr 17, 2026

Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2026

Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings - Insider Monkey

Apr 17, 2026

Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Apr 17, 2026

Apr 16, 2026

Boston Scientific: The Company That Never Turned Around - Yahoo

Apr 16, 2026

Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026 - Insider Monkey

Apr 16, 2026

INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire

Apr 16, 2026

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth - marketscreener.com

Apr 16, 2026

Boston Scientific Corporation $BSX Position Increased by KBC Group NV - MarketBeat

Apr 16, 2026

Apr 15, 2026

Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Apr 15, 2026

Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch

Apr 15, 2026

BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill

Apr 15, 2026